Cargando…

Treatment optimization of locally advanced and metastatic pancreatic cancer (Review)

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignant tumor types, being the sixth leading cause of mortality worldwide and the fourth in Europe. Globally, it has a mortality/incidence ratio of 98%, and the 5-year survival rate in Europe is only 3%. Although risk factors, such...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barros, Anabela G., Pulido, Catarina F., Machado, Manuela, Brito, Maria José, Couto, Nuno, Sousa, Olga, Melo, Sónia A., Mansinho, Hélder
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651228/ https://www.ncbi.nlm.nih.gov/pubmed/34859257 http://dx.doi.org/10.3892/ijo.2021.5290

Ejemplares similares

A Survival Model in Locally Advanced and Metastatic Pancreatic Ductal Adenocarcinoma
por: Wang, Yi, et al.
Publicado: (2018)

Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer
por: Cruz-Duarte, Raquel, et al.
Publicado: (2022)

IgG(+) Extracellular Vesicles Measure Therapeutic Response in Advanced Pancreatic Cancer
por: Couto, Nuno, et al.
Publicado: (2022)

Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma
por: Maximous, Doaa W, et al.
Publicado: (2009)

A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma
por: De Jesus-Acosta, Ana, et al.
Publicado: (2011)

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma
por: Hu, Jing, et al.
Publicado: (2011)

FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study
por: Rombouts, SJ, et al.
Publicado: (2016)

Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review
por: Sheahan, Anjali V., et al.
Publicado: (2018)

Nimotuzumab Concurrent with Gemcitabine as First-Line Treatment of Locally Advanced or Metastatic Pancreatic Adenocarcinoma
por: Sánchez, Yamirka, et al.
Publicado: (2023)

Protective Elements of Mental Health Status during the COVID-19 Outbreak in the Portuguese Population
por: Silva Moreira, Pedro, et al.
Publicado: (2021)

The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases
por: Ferreira, Arlindo, et al.
Publicado: (2016)

Bone metastasis risk factors in breast cancer
por: Pulido, Catarina, et al.
Publicado: (2017)

Case report: Irreversible electroporation for locally advanced pancreatic cancer
por: Orcutt, Sonia, et al.
Publicado: (2017)

Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients
por: Bittoni, Alessandro, et al.
Publicado: (2021)

First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis
por: Zhang, Shuisheng, et al.
Publicado: (2018)

Consolidative Chemoradiotherapy After Induced Chemotherapy Is an Optimal Regimen for Locally Advanced Pancreatic Cancer
por: Wu, Lili, et al.
Publicado: (2020)

Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival
por: Woeste, Matthew R., et al.
Publicado: (2022)

SMC3 epigenetic silencing regulates Rab27a expression and drives pancreatic cancer progression
por: Bastos, Nuno, et al.
Publicado: (2023)

Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses
por: Sultana, A, et al.
Publicado: (2008)

Intensity modulated radiotherapy for locally advanced and metastatic pancreatic cancer: a mono-institutional retrospective analysis
por: Wang, Zheng, et al.
Publicado: (2015)

Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer
por: Stein, Stacey M, et al.
Publicado: (2016)

Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment
por: Herman, Joseph M., et al.
Publicado: (2019)

Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients
por: Kieler, Markus, et al.
Publicado: (2020)

Sociodemographic and lifestyle predictors of mental health adaptability during COVID-19 compulsory confinement: A longitudinal study in the Portuguese population
por: Picó-Pérez, Maria, et al.
Publicado: (2021)

Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
por: Mansinho, André, et al.
Publicado: (2019)

Role of radio-ablative technique for optimizing the survival of patients with locally advanced pancreatic adenocarcinoma (Review)
por: Iancu, Ioana, et al.
Publicado: (2021)

The definition of locally advanced pancreatic cancer
por: Zanini, N, et al.
Publicado: (2010)

Treatment of locally advanced and metastatic bladder cancer
por: Khochikar, Makarand V.
Publicado: (2008)

Erdafitinib for locally advanced or metastatic urothelial carcinoma
por: Siefker-Radtke, Arlene O, et al.
Publicado: (2022)

Immunotherapy in Metastatic Mucosal Melanoma with Disseminated Intravascular Coagulation: A Case of Success
por: Luna Pais, Helena, et al.
Publicado: (2021)

Beta-HCG secretion by a pulmonary pleomorphic carcinoma: A case report
por: Dinis de Sousa, Magno, et al.
Publicado: (2021)

Early distant relapse after optimal local control in locally advanced rectal cancer
por: Gallego-Plazas, Javier, et al.
Publicado: (2008)

Individualized multimodal treatment strategy for metastatic rectal adenocarcinoma: Case report
por: Magalhães, Helena, et al.
Publicado: (2018)

Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis
por: Wang, Yuan, et al.
Publicado: (2016)

Reply to: The definition of locally advanced pancreatic cancer
por: Boeck, S, et al.
Publicado: (2010)

Management of Locally Advanced or Metastatic Combined Hepatocellular Cholangiocarcinoma
por: Zhao, Jemmy, et al.
Publicado: (2023)

Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer
por: Deng, G. C., et al.
Publicado: (2021)

Locally Advanced Pancreatic Cancer: A Review of Local Ablative Therapies
por: Ruarus, Alette, et al.
Publicado: (2018)

Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer
por: Rajeshkumar, N V, et al.
Publicado: (2016)

A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
por: Jo, Jung Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dea5mipbpruf4rgaqaj63n8gv7